FDA approval of wider use of implantable defibrillator

1996 ◽  
Author(s):  
Keyword(s):  
Implantable Defibrillator ◽  
Fda Approval

4-Hour Flu Detection Test Gains FDA Approval

2008 ◽  
Vol 39 (11) ◽  
pp. 40
Author(s):  
LORINDA BULLOCK
Keyword(s):  
Fda Approval

No Needle Needed: Postop Pain Controller Gains FDA Approval

2006 ◽  
Vol 39 (17) ◽  
pp. 27
Author(s):  
ELIZABETH MECHCATIE
Keyword(s):  
Fda Approval ◽  
Postop Pain

Third Treatment For Fibromyalgia Gets FDA Approval

2009 ◽  
Vol 42 (4) ◽  
pp. 1-2
Author(s):  
ELIZABETH MECHCATIE
Keyword(s):  
Fda Approval

Everolimus-Eluting Coronary Stent Wins FDA Approval

2008 ◽  
Vol 41 (18) ◽  
pp. 5
Author(s):  
ELIZABETH MECHCATIE
Keyword(s):  
Coronary Stent ◽  
Fda Approval

FDA Approval of Heart Devices Often Based on Scant Data

2010 ◽  
Vol 43 (2) ◽  
pp. 20
Author(s):  
MARY ANN MOON
Keyword(s):  
Fda Approval

FDA Approval Of Guaifenesin Products Denied

2007 ◽  
Vol 37 (12) ◽  
pp. 41
Author(s):  
ELIZABETH MECHCATIE
Keyword(s):  
Fda Approval

Chronic Mechanical Circulatory Support for Patients with End-stage Heart Failure as a Definitive Treatment Option

2010 ◽  
Vol 6 (4) ◽  
pp. 22
Author(s):  
Patrycja Ganslmeier ◽  
Christof Schmid ◽  
◽  
Keyword(s):  
Heart Failure ◽  
Mechanical Circulatory Support ◽  
Definitive Treatment ◽  
Circulatory Support ◽  
Randomized Evaluation ◽  
Fda Approval ◽  
Cerebrovascular Events ◽  
Device Placement ◽  
End Stage Heart Failure ◽  
End Stage

Mechanical circulatory support for end-stage heart failure has become routine and is now increasingly used as definitive treatment. Several small devices qualify for this purpose, but only a few have gained US Food and Drug Administration (FDA) approval as yet. Several studies, including the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) study, the Investigation of Non-transplant-Eligible Patients Who Are Inotrope Dependent (INTrEPID) and the HeartMate (HM) II trial have confirmed a significantly improved quality of life and functional capacity after device placement. However, cerebrovascular events, infection and device malfunction still pose a considerable risk to patients and hinder widespread use.

An exceptional cause of automatic implantable defibrillator dysfunction

2018 ◽  
Vol 39 (3) ◽  
pp. 166-168
Author(s):  
FA Benmessaoud ◽  
A Tazi Mezalek
Keyword(s):  
Implantable Defibrillator

Implantable defibrillator versus pharmacotherapy for Brugada syndrome

2010 ◽  
Author(s):  
Johnson Francis ◽  
Cibu Mathew
Keyword(s):  
Brugada Syndrome ◽  
Implantable Defibrillator
Sign in / Sign up

Export Citation Format

Share Document